Antegrade versus retrograde brain perfusion during low-moderate hypothermia for aortic hemi-arch surgery
Official title: Retrograde Versus Antegrade Perfusion in Low-Moderate Hypothermia for Aortic Arch Surgery
Run by Duke University · NCT06986967 · Data updated 2026-11-12
We will test whether giving blood to the brain in an antegrade versus a retrograde way better prevents confusion, delirium, or other thinking problems after elective proximal aortic reconstruction with hemi-arch replacement in adults.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 30 (estimated) |
| Sponsor | Duke University Academic / other |
| Drugs / interventions | chemotherapy, radiation |
| Locations | 2 sites (Durham, North Carolina and 1 other locations) |
| Status | Recruiting |
| Started | April 18, 2025 |
| Main results expected | December 2026 |
| Study ends | March 2027 |
| Registry record updated | September 3, 2026 |
| Trial ID | NCT06986967 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults over 18 scheduled for elective proximal aortic reconstructive surgery with proximal hemi-arch replacement who can complete baseline and follow-up cognitive testing and meet the study's medical criteria are the intended participants.
✕Probably not a fit
Patients with a history of symptomatic stroke with residual deficit, active substance abuse, current psychiatric illness requiring medication, severe organ failure, inability to read or complete cognitive tests, pregnant women, or those with low baseline cognitive scores are excluded and would not benefit from participation.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
The trial compares two methods of supplying blood to the brain (antegrade versus retrograde cerebral perfusion) during circulatory arrest with low-to-moderate hypothermia for proximal aortic reconstructive surgery including hemi-arch replacement. Patients undergo the planned surgical procedure and receive one of the two perfusion approaches while the heart-lung machine is stopped. Cognitive function is measured before and after surgery using standardized screening and testing (including MoCA and mood/depression scales) to track confusion, delirium, and agitation. The trial is conducted at Duke University and enrolls eligible adult surgical patients who can complete the cognitive testing.
Why it matters
Potential benefit: If one perfusion method is superior, patients could have fewer postoperative cognitive problems such as confusion, delirium, or agitation.
How similar studies have gone: Previous comparisons of antegrade versus retrograde cerebral perfusion have produced mixed results without a clear consensus, so the question remains unresolved.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. \> 18 years of age 2. Participant's that are scheduled for elective proximal aortic reconstructive surgery (ascending aorta + aortic valve or root) with concomitant proximal hemi-arch replacement via median sternotomy Exclusion Criteria: 1. \< 18 years of age 2. history of symptomatic cerebrovascular disease, e.g., prior stroke with residual deficit 3. current alcoholism (\> 2 drinks/day) 4. current psychiatric illness requiring pharmacotherapy 5. current drug abuse (any illicit drug use in the past 3 months) 6. hepatic insufficiency (liver function tests \> 1.5 times the upper limit of normal) 7. severe pulmonary insufficiency (requiring home oxygen therapy) 8. renal failure (serum creatinine \> 2.0 mg/dL) 9. claustrophobic fear 10. unable to read and thus unable to complete the cognitive testing 11. pregnant women 12. patients who score \<19 om the Montreal Cognitive Assessment (MoCA) or ≥27 on the baseline Center for Epidemiological Studies Depression (CES-D) scale 13. patients who have pre-existing unsafe implants for 3 Tesla magnetic resonance imaging (MRI) 14. Patients who have received chemotherapy in the last 12 months or radiation to the brain
Where it's running
-
Duke Univeristy
Durham, North Carolina, United States Recruiting -
Duke Univeristy
Durham, North Carolina, United States Not yet recruiting
Study contacts
- Study coordinator: Kelly Rodden, BSN
- Email: Kelly.Rodden@duke.edu
- Phone: 9196811804
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Brain and metabolic responses to different macronutrients in people with obesity
This trial will test whether three small, isocaloric liquid meals (glucose, fat, or protein) change brain activity and blood metabolites in adults with obesity and healthy-weight adults.
-
Evaluating brain function and psychological effects of cell therapy in autoimmune hemolytic anemia
This study is testing how CAR T-cell therapy affects thinking and mental health in people with autoimmune hemolytic anemia to help improve their treatment and quality of life.
-
Whole-brain activity during a natural menstrual cycle versus an ovarian stimulation cycle
This research will test whether hormonal changes from ovarian stimulation change resting brain activity in healthy young women with regular cycles.
-
Exploring brain function in action observation for patients with cerebral palsy
This study is trying to see how the brains of people with cerebral palsy work when they watch actions, using advanced MRI scans to better understand their brain connections and how it relates to their condition.
-
Impact of early intervention on child development in foster care vs. institutional care
This study is testing whether young children in foster care develop better than those in enhanced institutional care to see which option helps them grow up healthier.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.